WO2009061534A1 - Crosslinked polyolefins for biomedical applications and method of making same - Google Patents

Crosslinked polyolefins for biomedical applications and method of making same Download PDF

Info

Publication number
WO2009061534A1
WO2009061534A1 PCT/US2008/072482 US2008072482W WO2009061534A1 WO 2009061534 A1 WO2009061534 A1 WO 2009061534A1 US 2008072482 W US2008072482 W US 2008072482W WO 2009061534 A1 WO2009061534 A1 WO 2009061534A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
monomer
bcb
group
pendant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/072482
Other languages
French (fr)
Inventor
Yonghua Zhou
Leonard Pinchuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovia LLC
Original Assignee
Innovia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovia LLC filed Critical Innovia LLC
Priority to CA2705143A priority Critical patent/CA2705143C/en
Priority to KR1020107012514A priority patent/KR101523239B1/en
Priority to JP2010533131A priority patent/JP5605706B2/en
Priority to EP08797379A priority patent/EP2225291B1/en
Priority to BRPI0818904-8A priority patent/BRPI0818904A2/en
Priority to CN200880124361.XA priority patent/CN101918461B/en
Priority to MX2010005098A priority patent/MX2010005098A/en
Priority to ES08797379T priority patent/ES2408754T3/en
Publication of WO2009061534A1 publication Critical patent/WO2009061534A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00—Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/04—Monomers containing three or four carbon atoms
    • C08F210/08—Butenes
    • C08F210/10—Isobutene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/16—Intraocular lenses
    • A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00—Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/14—Monomers containing five or more carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02—Monomers containing only one unsaturated aliphatic radical
    • C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F212/06—Hydrocarbons
    • C08F212/08—Styrene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02—Monomers containing only one unsaturated aliphatic radical
    • C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F212/06—Hydrocarbons
    • C08F212/12—Monomers containing a branched unsaturated aliphatic radical or a ring substituted by an alkyl radical
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02—Monomers containing only one unsaturated aliphatic radical
    • C08F212/32—Monomers containing only one unsaturated aliphatic radical containing two or more rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F297/00—Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/247—Heating methods
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/16—Intraocular lenses
    • A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/16—Intraocular lenses
    • A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A61F2/1629—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing longitudinal position, i.e. along the visual axis when implanted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/16—Intraocular lenses
    • A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02—Monomers containing only one unsaturated aliphatic radical
    • C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F212/06—Hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2323/00—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers
    • C08J2323/02—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers not modified by chemical after treatment
    • C08J2323/18—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms
    • C08J2323/20—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms having four to nine carbon atoms
    • C08J2323/22—Copolymers of isobutene; butyl rubber
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2353/00—Characterised by the use of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives of such polymers

Definitions

  • This invention relates to polymeric materials.
  • the polymeric materials are particularly suitable for biomedical applications, such as a component of an intraocular lens.
  • SIBS is a thermoforming triblock copolymer consisting of polyisobutylene (PIB) as the rubbery center block and polystyrene (PS) as the hard side blocks. Due to the immiscibility of PIB and PS, the SIBS material has microphase-separated morphology in which PS phase forms physical crosslinks in the matrix of rubbery PIB phase. Due to the thermoplastic nature of the crosslinking, SIBS material creeps and can lose its dimension. SIBS doesn't withstand the high temperature of autoclave sterilization due to limitation by the glass transition temperature of PS. As a result, SIBS sterilization is difficult, because gamma-sterilization breaks down SIBS and ethylene oxide sterilization is cumbersome.
  • PIB polyisobutylene
  • PS polystyrene
  • PIB is commonly crosslinked through vulcanization.
  • isobutylene is copolymerized with a small fraction (1-5%) conjugated dienes such as butadiene, so that there are carbon-carbon double bonds in the backbone providing sites for vulcanization;
  • the isobutylene/butadiene copolymer is heated with sulfur and crosslinked by the sulfur.
  • either the polymer is activated as in the case of halo-butyl rubber, or accelerators are added such as resins, zinc oxide, xanthates and quinoid systems.
  • An extremely fast vulcanization process involves mixing butyl rubber solution with sulfur monochloride at room temperature (Erman et al, Macromolecules, Vol. 33, 2000, 4822-4827).
  • the chemicals used for vulcanization of butyl rubber are toxic to human body. Extraction by solvent is necessary for removal of toxic residuals, but complete extraction is difficult and time-consuming.
  • PIB can be crosslinked utilizing silicone chemistry.
  • Kaneka developed telechelic functional PIB (trade name: Epion) with silyl or allyl end groups, which can be crosslinked by moisture or adding silanes.
  • Faust et al disclosed a virtually telechelic silyl PIB, which undergoes room temperature crosslinking as described in US Patent No. 6268451.
  • the present invention provides a polymeric composition including alkenes and benzocyclobutene-functional olefins that is polymerizable using living carbocationic chemistry.
  • the present invention provides such a polymeric composition that is biostable, exhibits increased tensile strength, and does not require a filler.
  • the present invention provides such a polymeric composition that is suitable for many applications.
  • the present invention provides such a polymeric composition that is crosslinked in a manner such that it has improved creep resistance and/or dimensional stability, especially when stressed or at elevated temperatures.
  • the present invention provides such a polymeric composition that does not release a small molecule to the environment.
  • the present invention provides such a polymeric composition that can withstand high temperature sterilization.
  • the present invention provides such a polymeric composition that is chemically crosslinked at elevated temperatures (e.g., greater than 18O 0 C) without addition or evolution of small molecules.
  • a copolymer composition of the present invention includes, in polymerized form, a branched alkene which is cationically polymerizable as well as a glass-forming comonomer and/or a vinyl comonomer containing benzocyclobutene (herein called "BCB") as the pendant group.
  • the structure of the copolymer composition can take various forms: linear random copolymer, linear block copolymer, star random copolymer, star block copolymer, and other hyperbranched polymers and copolymers.
  • the copolymer composition preferably undergoes crosslinking reaction at elevated temperatures (preferably above 180 0 C).
  • the material of the present invention has improved structural characteristics and thus superior physical properties (such as creep resistance, heat resistance, dimensional stability and solvent resistance).
  • materials with variable hardness and crosslinking density can be obtained for various biomedical applications.
  • implantable medical devices such as synthetic heart valves, pharmaceutical closure devices, vertebral disks, joint menisci, artificial ligaments, artificial meniscuses, vascular grafts, pacemaker headers and lead insulators, glaucoma drainage tubes, intraocular lenses, and the like.
  • the material of the present invention also avoids the release of molecules that can cause inflammation when introduced in the body, which is characteristic of the silyl-terminated PIB of the prior art as it releases inflammation-introducing small molecules such as methanol, ethanol, acetic acid, chlorine and the like when cured.
  • FIG. 1 is a graph Gel Permeation Chromatography (GPC) analysis of two samples, one sample being polyisobutylene and the other sample being Poly(st-co-4VCB)-PIB-Poly(st- CO-4VCB).
  • GPC Gel Permeation Chromatography
  • FIG. 2 is a spectrum of NMR analysis of the Poly(st-co-4VCB)-PIB-Poly(st-co- 4VCB) sample of FIG. 1.
  • FIG. 3 is a graph GPC RI analysis of three samples of Poly(IB-co-4VCB) at various reaction times.
  • FIG. 4 is a GPC UV analysis of the Poly(IB-co-4VCB) samples of FIG. 3.
  • FIG. 5 is a spectrum of NMR analysis of a Poly(IB-co-4VCB) sample synthesized in accordance with the present invention.
  • FIG. 6 is a front view of an exemplary embodiment of an intraocular lens device in accordance with the present invention.
  • FIG. 7 is a front view of an alternate embodiment of an intraocular lens device in accordance with the present invention.
  • FIGS. 8A, 8B and 8C illustrate different annular haptic designs that can be utilized in the embodiment of FIG. 6.
  • a polymer composition suitable for biomedical applications includes copolymers comprising a plurality of constitutional units that correspond to one or more branched alkene monomer species as well as a plurality of constitutional units that correspond to one or more olefin monomer species with pendant BCB groups and/or a plurality of constitutional units that correspond to one or more glass-forming monomer species.
  • each of these constitutional units occurs with the copolymer molecule at a frequency of at least 2 times, and more typically at least 50, 100, 1000 or more times.
  • the copolymer composition preferably undergoes crosslinking reaction at elevated temperatures (preferably above 180 0 C).
  • BCB benzocyclobutene
  • o-xylylene Due to the strained four-membered ring, benzocyclobutene (BCB) is converted to o-xylylene at temperatures above 180 0 C. At such elevated temperatures, the BCB group undergoes Diels- Alder reactions with dienophiles to form a six-membered ring, or reacts with itself to form an eight-membered ring.
  • Polymers containing multiple pendant BCB groups per molecular chain can be thermally crosslinked with or without dienophiles. Each crosslink consists of a ring structure of carbon-carbon bond, which is more thermally stable than the sulfur bridge in vulcanized polymers and is stronger than the Si-O bond in silicone copolymers.
  • the BCB crosslinking only involves heat. As long as the polymer is stable at the crosslinking temperature, there is no toxic chemical involved.
  • An embodiment of this invention relates to a polymer that comprises (a) a plurality of constitutional units that include at least one cationically polymerizable branched alkene monomer; (b) a plurality of constitutional units that include at least one cationically polymerizable olefin monomer having a pendant benzocyclobutene (BCB) group; and optionally (c) a plurality of constitutional units that include at least one glass-forming monomer, e.g., styrenic monomer or a non-reactive glassy compound.
  • the constitutional units of the glass-forming monomer are present in the polymer.
  • the branched alkene monomer may be any monomer that is both branched and contains a single double bond.
  • the alkene should also be cationically polymerizable. Alkenes that are not cationically polymerizable, such as 1-hexene, cannot be added to the backbone of the polymer. Similarly, many dienes, such as 1,3 -butadiene, cannot propagate in a cationic polymerization reaction, as the secondary carbon in the vinyl group will frequently cause the reaction to terminate. As such, dienes are typically only added to the backbone of a polymer as a cap or mono-addition to a living end.
  • branched alkene monomers examples include C 4 -C 14 branched alkenes such as isobutylene, 2-methyl-l-butene, 2-methyl-l-pentene, 2 -methyl- 1-hexene, and beta- pinene.
  • the alkene monomer is a small-chain alkene, such as a C4-C7 alkene.
  • the branched alkene monomer is an isoolefm, such as isobutylene, 2-methyl-l- butene, or 2-methyl-l-pentene.
  • the olefin monomer having a pendant BCB group may be any olefin monomer containing at least one BCB-functional moiety in the olefin.
  • the olefin should be cationically polymerizable and compatible with the branched alkene.
  • Suitable olefin monomers having a pendant BCB group include 4-vinylbenzocyclobutene, 4-( ⁇ -alkylvinyl)benzocyclobutenes such as 2-(4-benzocyclobutenyl)-propene and 2-(4-benzocyclobutenyl)-l-butene, and 4-(2-methyl- alkenyl)benzocyclobutenes such as 2-methyl-3-(4-benzocyclobutenyl)-l-propene and 2- methyl-4-(4-benzocyclobutenyl)- 1 -butene .
  • Preferred olefin monomers having a pendant BCB group have the formula wherein R is hydrogen or an alkyl group (preferably methyl, ethyl, or propyl) and n is 0.
  • R is hydrogen or an alkyl group (preferably methyl, ethyl, or propyl) and n is 0.
  • examples of this type of preferred olefin monomer include 4-vinylbenzocyclobutene and 2-(4- benzocyclobutenyl)-propene.
  • Preferred olefin monomers having a pendant BCB group also include compounds having the same formula
  • R is an alkyl group (preferably methyl, ethyl, or propyl) and n is an integer ranging from 1-3.
  • R is an alkyl group (preferably methyl, ethyl, or propyl) and n is an integer ranging from 1-3.
  • preferred olefin monomers include 2-methyl-3-(4- benzocyclobutenyl)- 1 -propene and 2-methyl-4-(4-benzocyclobutenyl)- 1 -butene.
  • olefin monomers where n is 1-3 and R is hydrogen are not preferred, as these type of monomers are not cationically polymerizable.
  • any glass-forming monomer known to those of skill in the art can be used in the polymer.
  • suitable glass-forming monomers include styrenic monomers such as styrene, alpha-alkyl styrene (e.g., alpha-methyl styrene) , 4-alkylstyrene, 4-alkoxystyrene, and various benzene-ring substituted styrenes.
  • Suitable glass-forming monomers also include non- reactive glassy compounds such as norbornadiene or norbornene.
  • the non-reactive glassy compounds are preferably bicyclic bridged systems that obey Bredt's rule, which states that the bridgeheads cannot be involved in a double bond. Compounds falling under this rule are typically inert.
  • the glass-forming monomer is styrene.
  • the polymer may contain a plurality of constitutional units that include 1,3-dienes, vinyl ethers, N-vinyl ethers, N-vinyl carbazoles, N-vinyl pyrrolidone, aldehydes, ketones, or combinations thereof.
  • An embodiment of this invention is directed towards a polymer in which the alkene component is copolymerized with one or more 1,3-dienes.
  • Preferred 1,3-dienes include isoprene and 1,3 -butadiene. Because the 1,3-dienes cannot be homopolymerized by cationic polymerization, it is preferable that they are copolymerized with isobutylene or another suitable branched alkene.
  • An embodiment of this invention also relates to a method of preparing a polymer, comprising the step of cationically polymerizing (a) at least one branched alkene monomer; (b) at least one olefin monomer having a pendant benzocyclobutene group; and optionally (c) at least one glass-forming monomer.
  • the styrene is present.
  • the cationically polymerizable branched alkene monomer preferably contains a tertiary carbon on the vinyl group in the alkene.
  • cations are stable on the tertiary carbon due to the electron-donicity of the surrounding carbons that stabilize the positive charge of the cation.
  • Polyisobutylene, a preferred branched alkene monomer, as discussed above, is an example of an alkene monomer polymerizable by cationic chemical means that contains a tertiary carbon.
  • Molecules such as propene contain secondary carbons at the vinyl group and, as known by those of skill in the art, are not cationically polymerized.
  • Polymers based upon these alternating quaternary carbons cannot support a double bond on its backbone; therefore, these polymers are much more stable over time and are better suited for uses such as implants, where the polymer should ideally be able to stay in the host for an extended period of time.
  • the olefin monomer having a pendant benzocyclobutene (BCB) group should also be cationically polymerizable.
  • a similar mechanism in the olefin monomer enables this.
  • Olefins having a secondary carbon on the vinyl group are cationically polymerizable in instances when the electronegativity of the aromatic ring adjacent to the vinyl group can stabilize the cation.
  • olefins such as 4-vinylbenzocyclobutene, discussed above a preferred olefin, can be cationically polymerized.
  • These type of olefins can be easily incorporated into the polymer simply by titrating it into the reaction during its polymerization. This is different than, for example, the allyl-BCB, which cannot be added to a cationic polymerization, in part because the aromatic ring in the BCB is not adjacent to the vinyl group.
  • Olefins having a pendant BCB and a tertiary carbon on the vinyl group are also suitable for cationic polymerization even if the vinyl group is not adjacent to the aromatic ring of the BCB.
  • Tertiary carbons, which become quaternary carbons during polymerization, are stabilized by the electronegativity of the surrounding carbons. Therefore, olefins having tertiary carbons on the vinyl carbons can be incorporated into a cationic polymerized reaction much in the same manner as the alkene having a tertiary carbon is incorporated.
  • 2-Methyl-3- (4-benzocyclobutenyl)-propene is an example of this type of compound.
  • olefins that draw on the electronegativity of both the surrounding carbons and the aromatic ring, for example 2-(4-benzocyclobutenyl)-propene.
  • 2-(4-benzocyclobutenyl)-propene olefins that draw on the electronegativity of both the surrounding carbons and the aromatic ring.
  • These type of olefins will cationically polymerize as they are stabilized both by the methyl group (as in this case of 2-(4- benzocyclobutenyl)-propene) and the aromatic ring.
  • the olefin having a pendent BCB group can be added at any time, that is, during the alkene addition, after the alkene polymerization is completed (with or without the glass-forming monomer), or both.
  • the copolymers of the present invention embrace a variety of configurations, for example, cyclic, linear and branched configurations.
  • Branched configurations include star- shaped configurations (e.g., configurations in which three or more chains emanate from a single region), comb configurations (e.g., graft copolymers having a main chain and a plurality of side chains), and dendritic configurations (including arborescent or hyperbranched copolymers).
  • the copolymers of the present invention embrace (a) copolymers comprising one or more chains containing repeating constitutional units of a single type (e.g., block copolymers), (b) copolymers comprising one or more chains containing randomly distributed constitutional units of two or more types (e.g., random copolymers), (c) copolymers comprising one or more chains containing two or more types of constitutional units that repeat within an ongoing series (e.g., alternating copolymers), such as triblocks, quadblocks, and so forth.
  • alternating copolymers such as triblocks, quadblocks, and so forth.
  • the copolymers of the present invention are random copolymers containing (a) one or more alkene monomer units, which contain a plurality of units corresponding to one or more branched alkene monomer species and (b) one or more BCB-olefm monomer units, which contain a plurality of units corresponding to one or more BCB-olefin monomer species.
  • alkene monomer units which contain a plurality of units corresponding to one or more branched alkene monomer species
  • BCB-olefm monomer units which contain a plurality of units corresponding to one or more BCB-olefin monomer species. Examples of branched alkene monomer species and BCB-olefin monomer species are discussed above.
  • the copolymers of the present invention are block copolymers containing (a) one or more olefin monomer blocks, which contain a plurality of units corresponding to one or more branched alkene monomer species and (b) one or more BCB-olefin monomer blocks, which contain a plurality of units corresponding to one or more BCB-olefin monomer species.
  • olefin monomer blocks which contain a plurality of units corresponding to one or more branched alkene monomer species
  • BCB-olefin monomer species are discussed above.
  • the BCB-olefin blocks can further contain a plurality of units that correspond to glass-forming monomer species.
  • the number average molecular weight (Mn) of the block copolymers of the present invention typically range, for example, from about 1000 to about 2,000,000, more typically from about 10,000 to about 300,000, even more typically 50,000 to 150,000, with the BCB- olefin units typically comprising 0.01-60 mol %, more typically 0.5-40 mol %, even more typically 0.5-5 mol % of the polymer.
  • polymers have a narrow molecular weight distribution such that the ratio of weight average molecular weight to number average molecular weight (Mw/Mn) (i.e., the polydispersity index) of the polymers ranges from about 1.0 to about 2.5, or even from about 1.0 to about 1.2.
  • Living polymerization i.e., a polymerization that proceeds in the practical absence of chain transfer and termination, is a desirable objective in polymer synthesis.
  • Living cationic polymerization implies that a polymer can be grown from one or from a plurality of active sites in a controlled manner (controlled molecular weight, molecular weight distribution, end functionalities, etc.). During this growth process, different molecules can be incorporated into the backbone of the polymer, yielding polymers with well-defined structures.
  • SIBS poly(styrene- ⁇ /oc£-isobutylene- ⁇ /oc£-styrene)
  • SIBS poly(styrene- ⁇ /oc£-isobutylene- ⁇ /oc£-styrene)
  • polymers can be made with durometers from Shore 2OA to Shore 9OD with a wide range of elongations.
  • Another advantage of this triblock over a simple random polymerization of isobutylene and styrene is that the polymer blocks thus formed can segment into different domains which dramatically improve physical properties such as tensile strength, tear strength and compression set.
  • copolymers of the present invention are random copolymer
  • conventional polymerization is employed in polymer synthesis.
  • Random copolymers are formed by polymerizing monomer mixtures of (a) branched alkene monomer species (e.g., isobutylene) and (b) BCB-olefin monomer species (e.g., 4-vinylbenzocyclobutene or 2-(4-benzocyclobutenyl)-propene).
  • block copolymers are formed by the sequential monomer addition technique using (a) branched alkene monomer species (e.g., isobutylene) and (b) BCB-olefin monomer species (e.g., 4-vinylbenzocyclobutene or 2-(4- benzocyclobutenyl)-propene).
  • branched alkene monomer species e.g., isobutylene
  • BCB-olefin monomer species e.g., 4-vinylbenzocyclobutene or 2-(4- benzocyclobutenyl)-propene.
  • BCB-olefin monomer species e.g., 4-vinylbenzocyclobutene or 2-(4- benzocyclobutenyl)-propene.
  • a mixture of BCB-olefin and glass-forming monomer species may be used instead of BCB-olefin monomer species alone.
  • the copolymers of the present invention are block copolymers containing (a) one or more olefin monomer blocks, which contain a plurality of units corresponding to one or more branched alkene monomer species, such as isobutylene, copolymerized with (b) one or more BCB-olefin monomer species, to produce a polymer comprised of polyisobutylene (or other polyalkene) dispersed with BCB crosslinkable units.
  • branched alkene monomer species such as isobutylene
  • the copolymers described above containing polyisobutylene co-polymerized with BCB can be mixed in the melt (below 18O 0 C) with other copolymers.
  • the other copolymer may be, for instance, block copolymers containing (a) one or more glass-forming monomer blocks, which contain a plurality of units corresponding to one or more glass-forming monomer species, such as alpha-methyl styrene, copolymerized with (b) one or more BCB-olefm monomer species to produce a copolymer comprised of poly(alpha-methyl styrene) (or other glass-forming monomer) dispersed with BCB crosslinkable units.
  • these polyisobutylene polymers containing BCB crosslinkable units can crosslink to the poly(alpha- methyl styrene) polymers containing BCB crosslinkable units to form 3-dimentional thermoset materials that, depending upon the ratios of the above copolymers, can provide rubbery to stiff materials with exceptional physical and chemical properties.
  • the polymer is formed at low temperature from a reaction mixture that comprises: (a) a solvent system appropriate for cationic polymerization, (b) one or more branched alkene monomer species, (c) an initiator, and (d) a Lewis acid coinitiator.
  • a proton-scavenger is also typically provided to ensure the practical absence of protic impurities, such as water, which can lead to polymeric contaminants in the final product.
  • An inert nitrogen or argon atmosphere is generally required for the polymerization.
  • Polymerization can be conducted, for example, within a temperature range of from about 0 0 C to about -100 0 C, more typically from about -50 0 C to -90 0 C. Polymerization times are typically those times that are sufficient to reach the desired conversion.
  • solvent systems appropriate for cationic polymerization many of which are well known in the art, are included: (a) C1-C4 halogenated hydrocarbons, such as methyl chloride and methylene dichloride, (b) Cs-Cg aliphatic hydrocarbons, such as pentane, hexane, and heptane, (c) C5-C10 cyclic hydrocarbons, such as cyclohexane and methyl cyclohexane, and (d) mixtures thereof.
  • C1-C4 halogenated hydrocarbons such as methyl chloride and methylene dichloride
  • Cs-Cg aliphatic hydrocarbons such as pentane, hexane, and heptane
  • C5-C10 cyclic hydrocarbons such as cyclohexane and methyl cyclohexane
  • the solvent system contains a mixture of a polar solvent, such as methyl chloride, methylene chloride and the like, and a nonpolar solvent, such as hexane, cyclohexane or methylcyclohexane and the like.
  • a polar solvent such as methyl chloride, methylene chloride and the like
  • a nonpolar solvent such as hexane, cyclohexane or methylcyclohexane and the like.
  • Initiators for living carbocationic polymerization are commonly organic ethers, organic esters, organic alcohols, or organic halides, including tert-ester, tert-ether, tert- hydroxyl and tert-halogen containing compounds.
  • Specific examples include alkyl cumyl ethers, cumyl halides, alkyl cumyl esters, cumyl hydroxyl compounds and hindered versions of the same, for instance, dicumyl chloride, 5-tert-butyl,l,3-dicumyl chloride, and 5-tert-butyl- 1 ,3 -bis( 1 -methoxy- 1 -methylethyl)benzene .
  • 5 -tert-butyl- 1 ,3 -bis( 1 -methoxy- 1 - methylethyl)benzene is the preferred initiator for cationic polymerization and may be prepared through the methods disclosed in Wang B. et al., "Living carbocationic polymerization XII. Telechelic polyisobutylenes by a sterically hindered bifunctional initiator” Polym. Bull. (1987)17:205-11; or Mishra M.K., et al., "Living carbocationic polymerization VIII.
  • Carbocationically terminated star polymers can be formed by selecting initiators having three or more initiation sites, for example, tricumyl chloride (i.e., l,3,5-tris(l-chloroy- l-methylethyl)benzene), which contains three initiation sites.
  • tricumyl chloride i.e., l,3,5-tris(l-chloroy- l-methylethyl)benzene
  • Lewis acid coinitiators include metal halides such as boron trichloride, titanium tetrachloride and alkyl aluminum halides.
  • the Lewis acid coinitiator is typically used in concentrations equal to or greater, e.g., 2 to 50 times greater, than the concentration of the initiator.
  • proton-scavengers also referred to as proton traps
  • proton traps include substituted or unsubstituted 2,6-di-tert-butylpyridines, such as 2,6-di-tert-butylpyridine and 4-methyl-2,6- di-tert-butylpyridine, as well as l,8-bis(dimethylamino)-naphthalene and diisopropylethyl amine.
  • concentration of the proton trap is preferably only slightly higher than the concentration of protic impurities such as water in the polymerization system.
  • a beneficial aspect of this invention is that the polymers make excellent thermoplastics.
  • the resultant thermoplastic polymer can be cleaned by multiple dissolution and precipitation procedures, which can be especially useful in medical applications, as it is still soluble in solvents.
  • the polymer can then be molded or extruded or cast into its desired shape and then heat cured to react the olefin having the pendant BCB group with itself to crosslink the polymer into a thermoset shape.
  • the resultant product provides better heat stability, better creep resistance, less water uptake, and less swelling or solubility in organic solvents.
  • Another advantage of a thermoset polymer is that the polymer can be heat or solvent compounded with plasticizers including polyisobutylene, mineral oil, paraffin oil and the like to soften the polymer.
  • the polymer can be used for heart valves, vertebral disks, dynamic stabilizers, sealable vascular grafts, stent grafts, intraocular lens (e.g., accommodating intraocular lenses), glaucoma drainage implants, pacemaker headers, pacemaker lead insulators and other implantable medical devices as well as other medical devices where exceptional compression set or creep resistance are important. Additionally, the polymers have use for various uses outside the biomedical field, such use as O-rings or as components of windshield wipers.
  • Example 1 Synthesis of polv(st-co-4VBCB)-polvIB-polv(st-co-4VBCB) triblock copolymer
  • methylcyclohexane (MeCHx) were added to a glass reaction vessel equipped with mechanical stirrer, stainless steel serpentine tubing for liquid nitrogen cooling, stainless steel tubing for feeding methyl chloride (MeCl) and isobutylene (IB) into the vessel, a thermocouple with temperature controller, a nitrogen bubbler and an addition dropping funnel.
  • the liquid was cooled down to -80 0 C by liquid nitrogen cooling.
  • Sequentially MeCl (189g) and IB (2Og) were added through the feeding line immersed in the liquid, so that the gases are condensed into the liquid.
  • an initiator solution (HDCE/DTBP/MeCHx 0.28g/0.45mL/15mL) was added through a port on the reactor lid.
  • TiCl 4 (3.5 mL, use a 10 cc glass syringe) was then added through an opening in the reactor lid, which started the IB polymerization (the timer is started).
  • ⁇ 4 mL of reaction mixture was withdrawn from the reactor and quenched in excess methanol.
  • reaction mixture was stored under the fume hood overnight. The top layer was separated and washed repeatedly with distilled water until neutral. The solution was precipitated into isopropyl alcohol, followed by dissolution in toluene and precipitation in isopropyl alcohol again. The precipitate was dried in a vacuum oven at ⁇ 60 0 C until constant weight (yield: 22g).
  • the polymer was characterized by GPC and NMR. As shown in Figure 1 , both the starting PIB (low elution volume) and the triblock copolymer (high elution volume) show a narrow monodispersed peak in GPC RI traces, and the traces shift smoothly as molecular weight increases. As shown in Figure 2, there is a singlet at ⁇ 3.1 ppm in proton NMR spectrum, which is attributed to the strained ring of BCB. The broad peaks at -6.4-7.3 ppm are attributed to aromatic protons on styrene and 4-VBCB monomer units. From the relative integration intensities, the copolymer was determined to have ⁇ 3 mol% 4-VBCB and ⁇ 7 mol% styrene.
  • methylcyclohexane (MeCHx) were added to a glass reaction vessel equipped with mechanical stirrer, stainless steel tubing for liquid nitrogen cooling, stainless steel tubing for feeding methyl chloride (MeCl) and isobutylene (IB) into the vessel, a thermocouple with temperature controller, a nitrogen bubbler and an addition dropping funnel.
  • the liquid was cooled down to -80 0 C by liquid nitrogen cooling.
  • Sequentially MeCl (189g) and IB (5g) were added through the feeding line immersed in the liquid, so that the gases are condensed into the liquid.
  • an initiator solution (HDCE/DTBP/MeCHx 0.28g/0.45mL/15mL) was added through a port on the reactor lid.
  • TiCl 4 (3.5 mL, using a 10 cc glass syringe) was then added through an opening in the reactor lid, which starts the IB polymerization (the timer was started).
  • 36g of IB and 1.5g 4VBCB (dissolved in 10 niL of MeCHx) were added slowly, taking 7 min and 9.5 min, respectively. After all 4-VBCB was added, the reaction is kept going for 60 min. Samples were taken at 5, 30 and 60 min. The reaction was quenched with excess methanol in the end.
  • the polymer was characterized by GPC and proton NMR.
  • GPC RI traces of the samples show (see Figure 3) that the molecular weight increases with reaction time. Little change was observed in molecular weight (-10%) from 30min to 60min, as the polymerization approached completion.
  • Each sample had a UV signal with similar elution volume as its RI signal ( Figure 3, 4).
  • the sample taken at 5 min exhibited a much stronger UV signal than the other two, indicating that it has a higher 4-VBCB content at lower conversion.
  • the incorporation of 4-VBCB into the copolymer was further confirmed by proton NMR spectroscopy. A singlet at ⁇ 3.1 ppm was seen in proton NMR spectrum (Figure 5), which is attributed to the strained ring of BCB.
  • Example 3 Thermal crosslinking of polv(st-co-4VBCB)-polvIB-polv(st-co-4VBCB) triblock copolymer
  • SIBS was prepared in two steps in one pot.
  • isobutylene was polymerized by a 5-tert-butyl,l,3-dicumyl chloride/TiCU initiating system in a methyl chloride/hexanes solvent system in the presence of a proton trap under a blanket of dry nitrogen at -8O 0 C.
  • the central PIB block reached the desired molecular weight, in this case 50 KDaltons
  • a sample was removed from the reactor and styrene was added to the reactor and the polymerization continued until the outer polystyrene blocks also reach a predetermined length, in this case 75 KDaltons.
  • the process was terminated by the addition of methanol.
  • the sample that was taken was dried in an oven. After drying in the oven, the sample was observed to have a consistency similar to that of a rubber band.
  • the polymeric material as described herein realizes an intraocular lens (IOL) for the replacement of the natural crystalline lens of the eye.
  • the natural crystalline lens is a gel-like material that sits within the lens capsule of the eye and when the lens capsule is stretched by the zonules, the gel changes its thickness and therefore its focal point thereby allowing focusing at different distances.
  • lens epithelial cells LECs
  • LECs lens epithelial cells
  • PCO posterior capsule opacification
  • the LECs also spread on the anterior wall.
  • the polymeric material as described herein is used to form a one-piece IOL that includes an optic portion with an outer peripheral edge as well as one or more haptic elements (or haptics) that project radially outward from the peripheral edge of optic portion as shown in FIGS. 6 - 8C.
  • the IOL 100 includes an optic portion 102 with an outer peripheral edge 103.
  • Three haptic elements 104A, 104B, 104C project radially outward from the peripheral edge 103 of optic portion 102.
  • the haptic elements 104 are preferably integrally formed with and permanently connected to the outer peripheral edge 103 of optic portion 102. Different haptic designs, such as those that utilize two haptics or four haptics can also be used.
  • FIGS. 7 - 8 A the IOL 100' employs a ring haptic 104' as is well known in the art.
  • FIG. 7 illustrates a top view of the IOL 100' with an optic portion 102" and a ring haptic 104'. Cross-sections for different embodiments are shown in FIGS. 8A-8C.
  • the front and back surfaces of optic portion 102' can be of any diopter (curvature) necessary to provide the desired correction for the patient.
  • the front surface of the optic portion 104' may be convex as shown in FIGS. 8A-8C or possibly concave (not shown).
  • the back surface of the optic portion 104' is preferably flat as shown in FIGS.
  • the angle ⁇ of the annulus of the ring haptic 104' relative to the plane of the optic portion 104' is between 0 and 45 degrees, and more preferably between 10 and 20 degrees, and most preferably 15 degrees.
  • the terminal end(s) of the haptic(s) of the IOL as described herein are adapted to rest in and engage the lens capsule where such terminal end(s) is(are) held in place through compressive forces exerted by the inner surfaces of the lens capsule.
  • the haptic(s) preferably do not lie in the plane of the optic portion but are angled relative to the optic portion (for example, at 15 degrees) such that posterior side of the optics portion presses against and contacts the posterior wall of the lens capsule.
  • This configuration (which is typically referred to as a "vaulted configuration” or “vaulted haptics”) is important because the pressure of the optics portion against the posterior wall of the lens capsule prevents epithelial cells from migrating between the optics portion and the posterior wall and thereby mitigates the occurrence of PCO. Moreover, due to the crosslinked nature of the polymeric material as described herein, the vaulted haptics realized from such polymeric material maintain pressure of the optics portion against the posterior wall of the lens capsule over time and thus mitigates the occurrence of PCO over time.
  • the haptics of the IOL act as a hinge which allows the optics portion to move forward or backwards along the optical axis of the eye.
  • the crosslinked nature of the polymeric material as described herein allows for such hinged movement while providing memory that returns the haptics to their original shape during such accommodation.
  • the polymeric material as described herein better resists fatigue under the flex stresses imposed during accommodation as compared to the acrylic lenses currently on the market. More specifically, acrylic lenses are not used for accommodating IOLs for this reason.
  • silicone is used for accommodating IOLs, but silicone IOLs are thick
  • the polymeric material as described herein provides an index of refraction in the range between 1.525 and 1.535 as compared to an index of refraction between 1.25 and 1.42 for silicone rubber.
  • This higher index of refraction provides greater magnification as compared to silicone rubber, which enables the IOL realized from the polymeric material described herein to be thinner than silicone rubber IOLs.
  • a thin IOL is advantageous as it can be introduced into lens capsule through a smaller size cannula and thus reduces the size of the surgical incision into the lens capsule. The reduced size incision lessens the chance of an astigmatism that can possibly result therefrom when the incision is sutured closed.
  • the thin IOL can be deployed into the lens capsule through an incision less than 2.5mm. In this case, a suture is not necessary to close the incision and astigmatisms are not a concern.
  • the polymeric material of the IOL includes PIB crosslinked by at least one BCB-olefm monomer as described herein due to the homogeneity of such material. It is also contemplated that the polymeric material of the IOL can be made gel like to form a phako-ersatz lens.
  • the polymeric material as described herein can be made into a gel for realizing the IOL by blending in, either with heat or in solvent, plasticizers such as low molecular weight PIB, mineral oil, paraffin oil, organic solvents (toluene, hexane, heptane, octane, nonane, decane, dodecane, etc.) or any other aliphatic plasticizer.
  • plasticizers such as low molecular weight PIB, mineral oil, paraffin oil, organic solvents (toluene, hexane, heptane, octane, nonane, decane, dodecane, etc.) or any other aliphatic plasticizer.
  • plasticizers such as low molecular weight PIB, mineral oil, paraffin oil, organic solvents (toluene, hexane, heptane, octane, nonane, decane, dodecane, etc.
  • the PIB When PIB is used as part of the polymeric material of the IOL, the PIB is typically synthesized in organic solvent using a Lewis acid as an initiator.
  • a Lewis acid that is preferred for this application is titanium tetrachloride.
  • chemicals such as alcohols (methanol, for example) are added in excess to the reaction stoicheometry which immediately quenches the reaction by neutralizing titanium tetrachloride.
  • titanium tetrachloride is converted into various salts of titanium, including titanium dioxide, titanium methoxide, and the like.
  • the polymer When used as an IOL, the polymer can be compounded with radiopaque fillers and the like to enable visualization under X-ray or angiography.
  • radiopaque fillers and the like to enable visualization under X-ray or angiography.
  • Other fillers and additives known in the art of preparing an IOL can also be added using known techniques and procedures.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Graft Or Block Polymers (AREA)

Abstract

The invention relates to a polymer composition that includes a branched alkene which is cationically polymerizable as well as a glass-forming comonomer and/or a vinyl comonomer containing benzocyclobutene as the pendant group. The structure of the polymer composition can take various forms: linear random copolymer, linear block copolymer, star random copolymer, star block copolymer, and other hyperbranched polymers. The copolymer composition can undergoes crosslinking at elevated temperatures (preferably above 180 0C).

Description

CROSSLINKED POLYOLEFINS FOR BIOMEDICAL APPLICATIONS AND
METHOD OF MAKING SAME
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
[0001] This invention relates to polymeric materials. The polymeric materials are particularly suitable for biomedical applications, such as a component of an intraocular lens.
STATE OF THE ART
[0002] Polymers have been used in biomedical applications for a long time. Early in vivo studies on polymeric implants revealed that the polymers are susceptible to degradation in physiological environment and lose integrity over time. A close scrutiny of the structure and bio-properties relationship led to Pinchuk's discovery of the superior biostability of polyisobutylene-based materials. The biomedical application of polyisobutylene-based materials is disclosed in U.S. Patent Nos. 5,741,331; 6,102,939; 6,197,240; 6,545,097; and 6,855,770, all of which are herein incorporated by reference in their entirety. The first commercial application of such materials is the use of SIBS in the TAXUS® Stent of Boston Scientific Corporation, which is regarded as the most successful launch of a biomedical device in history.
[0003] SIBS is a thermoforming triblock copolymer consisting of polyisobutylene (PIB) as the rubbery center block and polystyrene (PS) as the hard side blocks. Due to the immiscibility of PIB and PS, the SIBS material has microphase-separated morphology in which PS phase forms physical crosslinks in the matrix of rubbery PIB phase. Due to the thermoplastic nature of the crosslinking, SIBS material creeps and can lose its dimension. SIBS doesn't withstand the high temperature of autoclave sterilization due to limitation by the glass transition temperature of PS. As a result, SIBS sterilization is difficult, because gamma-sterilization breaks down SIBS and ethylene oxide sterilization is cumbersome. [0004] PIB is commonly crosslinked through vulcanization. First, isobutylene is copolymerized with a small fraction (1-5%) conjugated dienes such as butadiene, so that there are carbon-carbon double bonds in the backbone providing sites for vulcanization; second, the isobutylene/butadiene copolymer is heated with sulfur and crosslinked by the sulfur. To accelerate the vulcanization process, either the polymer is activated as in the case of halo-butyl rubber, or accelerators are added such as resins, zinc oxide, xanthates and quinoid systems. An extremely fast vulcanization process involves mixing butyl rubber solution with sulfur monochloride at room temperature (Erman et al, Macromolecules, Vol. 33, 2000, 4822-4827). The chemicals used for vulcanization of butyl rubber are toxic to human body. Extraction by solvent is necessary for removal of toxic residuals, but complete extraction is difficult and time-consuming.
[0005] PIB can be crosslinked utilizing silicone chemistry. Kaneka developed telechelic functional PIB (trade name: Epion) with silyl or allyl end groups, which can be crosslinked by moisture or adding silanes. Faust et al disclosed a virtually telechelic silyl PIB, which undergoes room temperature crosslinking as described in US Patent No. 6268451.
[0006] Benzocyclobutene derivates and 1-hexene were analyzed in Fishback et al., "A New Non- Toxic, Curing Agent for Synthetic Polyolefms," Bio-Medical Materials and Engineering, Vol. 2, pp. 83-87 (1992), herein incorporated in reference in its entirety. Fishback prepared polymers containing 1-hexene, allyl-benzocyclobutene, and a diene, either 7-methyl-l,6-octadiene or 5-methyl-l,4-hexadiene, using free-radical polymerization techniques. While the polymer showed improved properties, it requires carbon black as a filler, and is polymerizable only through free-radical chemistry techniques that necessitate the use of free radical initiators. Additionally, there is a need to extract the non-crosslinked polymers to rid the system of the initiators as the initiators, if not removed, would leave the polymer with an undesirable purple color. SUMMARY OF THE INVENTION
[0007] The present invention provides a polymeric composition including alkenes and benzocyclobutene-functional olefins that is polymerizable using living carbocationic chemistry.
[0008] The present invention provides such a polymeric composition that is biostable, exhibits increased tensile strength, and does not require a filler.
[0009] The present invention provides such a polymeric composition that is suitable for many applications.
[0010] The present invention provides such a polymeric composition that is crosslinked in a manner such that it has improved creep resistance and/or dimensional stability, especially when stressed or at elevated temperatures.
[0011 ] The present invention provides such a polymeric composition that does not release a small molecule to the environment.
[0012] The present invention provides such a polymeric composition that can withstand high temperature sterilization.
[0013] The present invention provides such a polymeric composition that is chemically crosslinked at elevated temperatures (e.g., greater than 18O0C) without addition or evolution of small molecules.
[0014] A copolymer composition of the present invention includes, in polymerized form, a branched alkene which is cationically polymerizable as well as a glass-forming comonomer and/or a vinyl comonomer containing benzocyclobutene (herein called "BCB") as the pendant group. The structure of the copolymer composition can take various forms: linear random copolymer, linear block copolymer, star random copolymer, star block copolymer, and other hyperbranched polymers and copolymers. The copolymer composition preferably undergoes crosslinking reaction at elevated temperatures (preferably above 180 0C). [0015] It will be appreciated that the material of the present invention has improved structural characteristics and thus superior physical properties (such as creep resistance, heat resistance, dimensional stability and solvent resistance). By changing the copolymer composition and structure, materials with variable hardness and crosslinking density can be obtained for various biomedical applications. Examples of such uses include implantable medical devices such as synthetic heart valves, pharmaceutical closure devices, vertebral disks, joint menisci, artificial ligaments, artificial meniscuses, vascular grafts, pacemaker headers and lead insulators, glaucoma drainage tubes, intraocular lenses, and the like.
[0016] The material of the present invention also avoids the release of molecules that can cause inflammation when introduced in the body, which is characteristic of the silyl-terminated PIB of the prior art as it releases inflammation-introducing small molecules such as methanol, ethanol, acetic acid, chlorine and the like when cured.
[0017] Additional objects and advantages of the invention will become apparent to those skilled in the art upon reference to the detailed description taken in conjunction with the provided figures.
BRIEF DESCRIPTION OF THE DRAWINGS
[0018] FIG. 1 is a graph Gel Permeation Chromatography (GPC) analysis of two samples, one sample being polyisobutylene and the other sample being Poly(st-co-4VCB)-PIB-Poly(st- CO-4VCB).
[0019] FIG. 2 is a spectrum of NMR analysis of the Poly(st-co-4VCB)-PIB-Poly(st-co- 4VCB) sample of FIG. 1.
[0020] FIG. 3 is a graph GPC RI analysis of three samples of Poly(IB-co-4VCB) at various reaction times.
[0021] FIG. 4 is a GPC UV analysis of the Poly(IB-co-4VCB) samples of FIG. 3.
[0022] FIG. 5 is a spectrum of NMR analysis of a Poly(IB-co-4VCB) sample synthesized in accordance with the present invention. [0023] FIG. 6 is a front view of an exemplary embodiment of an intraocular lens device in accordance with the present invention.
[0024] FIG. 7 is a front view of an alternate embodiment of an intraocular lens device in accordance with the present invention.
[0025] FIGS. 8A, 8B and 8C illustrate different annular haptic designs that can be utilized in the embodiment of FIG. 6.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] In accordance with the present invention, a polymer composition suitable for biomedical applications includes copolymers comprising a plurality of constitutional units that correspond to one or more branched alkene monomer species as well as a plurality of constitutional units that correspond to one or more olefin monomer species with pendant BCB groups and/or a plurality of constitutional units that correspond to one or more glass-forming monomer species. Typically, each of these constitutional units occurs with the copolymer molecule at a frequency of at least 2 times, and more typically at least 50, 100, 1000 or more times. The copolymer composition preferably undergoes crosslinking reaction at elevated temperatures (preferably above 180 0C).
[0027] Due to the strained four-membered ring, benzocyclobutene (BCB) is converted to o-xylylene at temperatures above 180 0C. At such elevated temperatures, the BCB group undergoes Diels- Alder reactions with dienophiles to form a six-membered ring, or reacts with itself to form an eight-membered ring. Polymers containing multiple pendant BCB groups per molecular chain can be thermally crosslinked with or without dienophiles. Each crosslink consists of a ring structure of carbon-carbon bond, which is more thermally stable than the sulfur bridge in vulcanized polymers and is stronger than the Si-O bond in silicone copolymers. The BCB crosslinking only involves heat. As long as the polymer is stable at the crosslinking temperature, there is no toxic chemical involved.
[0028] An embodiment of this invention relates to a polymer that comprises (a) a plurality of constitutional units that include at least one cationically polymerizable branched alkene monomer; (b) a plurality of constitutional units that include at least one cationically polymerizable olefin monomer having a pendant benzocyclobutene (BCB) group; and optionally (c) a plurality of constitutional units that include at least one glass-forming monomer, e.g., styrenic monomer or a non-reactive glassy compound. Preferably, the constitutional units of the glass-forming monomer are present in the polymer.
[0029] The branched alkene monomer may be any monomer that is both branched and contains a single double bond. The alkene should also be cationically polymerizable. Alkenes that are not cationically polymerizable, such as 1-hexene, cannot be added to the backbone of the polymer. Similarly, many dienes, such as 1,3 -butadiene, cannot propagate in a cationic polymerization reaction, as the secondary carbon in the vinyl group will frequently cause the reaction to terminate. As such, dienes are typically only added to the backbone of a polymer as a cap or mono-addition to a living end. See De et al., "Relative Reactivity of C4 Olefins toward the Polyisobutylene Cation," Macromolecules, 39 (2006) pp. 6861-70. Additionally, effective cationic polymerization can be difficult using dienes having sterically hindered tertiary carbons.
[0030] Examples of suitable branched alkene monomers include C4-C 14 branched alkenes such as isobutylene, 2-methyl-l-butene, 2-methyl-l-pentene, 2 -methyl- 1-hexene, and beta- pinene. Preferably, the alkene monomer is a small-chain alkene, such as a C4-C7 alkene. More preferably, the branched alkene monomer is an isoolefm, such as isobutylene, 2-methyl-l- butene, or 2-methyl-l-pentene.
[0031 ] The olefin monomer having a pendant BCB group may be any olefin monomer containing at least one BCB-functional moiety in the olefin. The olefin should be cationically polymerizable and compatible with the branched alkene. Suitable olefin monomers having a pendant BCB group include 4-vinylbenzocyclobutene, 4-(α-alkylvinyl)benzocyclobutenes such as 2-(4-benzocyclobutenyl)-propene and 2-(4-benzocyclobutenyl)-l-butene, and 4-(2-methyl- alkenyl)benzocyclobutenes such as 2-methyl-3-(4-benzocyclobutenyl)-l-propene and 2- methyl-4-(4-benzocyclobutenyl)- 1 -butene .
[0032] Preferred olefin monomers having a pendant BCB group have the formula
Figure imgf000008_0001
wherein R is hydrogen or an alkyl group (preferably methyl, ethyl, or propyl) and n is 0. Examples of this type of preferred olefin monomer include 4-vinylbenzocyclobutene and 2-(4- benzocyclobutenyl)-propene.
[0033] Preferred olefin monomers having a pendant BCB group also include compounds having the same formula
Figure imgf000008_0002
but wherein R is an alkyl group (preferably methyl, ethyl, or propyl) and n is an integer ranging from 1-3. Examples of this type of preferred olefin monomers include 2-methyl-3-(4- benzocyclobutenyl)- 1 -propene and 2-methyl-4-(4-benzocyclobutenyl)- 1 -butene.
[0034] As can be seen from the above formulas, which are identical, olefin monomers where n is 1-3 and R is hydrogen (for instance, allyl-benzocyclobutene) are not preferred, as these type of monomers are not cationically polymerizable.
[0035] Any glass-forming monomer known to those of skill in the art can be used in the polymer. Examples of suitable glass-forming monomers include styrenic monomers such as styrene, alpha-alkyl styrene (e.g., alpha-methyl styrene) , 4-alkylstyrene, 4-alkoxystyrene, and various benzene-ring substituted styrenes. Suitable glass-forming monomers also include non- reactive glassy compounds such as norbornadiene or norbornene. The non-reactive glassy compounds are preferably bicyclic bridged systems that obey Bredt's rule, which states that the bridgeheads cannot be involved in a double bond. Compounds falling under this rule are typically inert. Preferably, the glass-forming monomer is styrene.
[0036] Additional olefins that are cationically polymerizable may also added to the polymer. For instance, the polymer may contain a plurality of constitutional units that include 1,3-dienes, vinyl ethers, N-vinyl ethers, N-vinyl carbazoles, N-vinyl pyrrolidone, aldehydes, ketones, or combinations thereof. An embodiment of this invention is directed towards a polymer in which the alkene component is copolymerized with one or more 1,3-dienes. Preferred 1,3-dienes include isoprene and 1,3 -butadiene. Because the 1,3-dienes cannot be homopolymerized by cationic polymerization, it is preferable that they are copolymerized with isobutylene or another suitable branched alkene.
[0037] An embodiment of this invention also relates to a method of preparing a polymer, comprising the step of cationically polymerizing (a) at least one branched alkene monomer; (b) at least one olefin monomer having a pendant benzocyclobutene group; and optionally (c) at least one glass-forming monomer. In a preferred embodiment, the styrene is present.
[0038] The cationically polymerizable branched alkene monomer preferably contains a tertiary carbon on the vinyl group in the alkene. As known by those of skill in the art, cations are stable on the tertiary carbon due to the electron-donicity of the surrounding carbons that stabilize the positive charge of the cation. Polyisobutylene, a preferred branched alkene monomer, as discussed above, is an example of an alkene monomer polymerizable by cationic chemical means that contains a tertiary carbon. Molecules such as propene contain secondary carbons at the vinyl group and, as known by those of skill in the art, are not cationically polymerized.
[0039] Secondary carbons on the vinyl group after polymerization undesirably leave tertiary hydrogens that are easily extracted by simple oxidation means or even acid means to form double bonds. Therefore polymers of alkenes or olefins containing tertiary hydrogens, such as polypropylene and poly(l-hexene), tend to oxidize over time and become brittle. Consequently, alkenes having secondary carbons are not desirable for cationic polymerization reactions. On the other hand, alkenes containing tertiary carbons will form alternating quaternary carbons upon polymerizations. Polymers based upon these alternating quaternary carbons cannot support a double bond on its backbone; therefore, these polymers are much more stable over time and are better suited for uses such as implants, where the polymer should ideally be able to stay in the host for an extended period of time.
[0040] Like the branched alkene, the olefin monomer having a pendant benzocyclobutene (BCB) group should also be cationically polymerizable. A similar mechanism in the olefin monomer enables this. Olefins having a secondary carbon on the vinyl group are cationically polymerizable in instances when the electronegativity of the aromatic ring adjacent to the vinyl group can stabilize the cation. Thus olefins such as 4-vinylbenzocyclobutene, discussed above a preferred olefin, can be cationically polymerized. These type of olefins can be easily incorporated into the polymer simply by titrating it into the reaction during its polymerization. This is different than, for example, the allyl-BCB, which cannot be added to a cationic polymerization, in part because the aromatic ring in the BCB is not adjacent to the vinyl group.
[0041] Olefins having a pendant BCB and a tertiary carbon on the vinyl group are also suitable for cationic polymerization even if the vinyl group is not adjacent to the aromatic ring of the BCB. Tertiary carbons, which become quaternary carbons during polymerization, are stabilized by the electronegativity of the surrounding carbons. Therefore, olefins having tertiary carbons on the vinyl carbons can be incorporated into a cationic polymerized reaction much in the same manner as the alkene having a tertiary carbon is incorporated. 2-Methyl-3- (4-benzocyclobutenyl)-propene is an example of this type of compound. Also preferred are olefins that draw on the electronegativity of both the surrounding carbons and the aromatic ring, for example 2-(4-benzocyclobutenyl)-propene. These type of olefins will cationically polymerize as they are stabilized both by the methyl group (as in this case of 2-(4- benzocyclobutenyl)-propene) and the aromatic ring.
[0042] Method of preparing polymers via cationic polymerization are well known in the art. During the carbocationic polymerization process, the olefin having a pendent BCB group can be added at any time, that is, during the alkene addition, after the alkene polymerization is completed (with or without the glass-forming monomer), or both.
[0043] The copolymers of the present invention embrace a variety of configurations, for example, cyclic, linear and branched configurations. Branched configurations include star- shaped configurations (e.g., configurations in which three or more chains emanate from a single region), comb configurations (e.g., graft copolymers having a main chain and a plurality of side chains), and dendritic configurations (including arborescent or hyperbranched copolymers). The copolymers of the present invention embrace (a) copolymers comprising one or more chains containing repeating constitutional units of a single type (e.g., block copolymers), (b) copolymers comprising one or more chains containing randomly distributed constitutional units of two or more types (e.g., random copolymers), (c) copolymers comprising one or more chains containing two or more types of constitutional units that repeat within an ongoing series (e.g., alternating copolymers), such as triblocks, quadblocks, and so forth.
[0044] For example, in certain beneficial embodiments, the copolymers of the present invention are random copolymers containing (a) one or more alkene monomer units, which contain a plurality of units corresponding to one or more branched alkene monomer species and (b) one or more BCB-olefm monomer units, which contain a plurality of units corresponding to one or more BCB-olefin monomer species. Examples of branched alkene monomer species and BCB-olefin monomer species are discussed above.
[0045] For another example, in certain beneficial embodiments, the copolymers of the present invention are block copolymers containing (a) one or more olefin monomer blocks, which contain a plurality of units corresponding to one or more branched alkene monomer species and (b) one or more BCB-olefin monomer blocks, which contain a plurality of units corresponding to one or more BCB-olefin monomer species. Examples of branched alkene monomer species and BCB-olefin monomer species are discussed above. As above, in some embodiments, the BCB-olefin blocks can further contain a plurality of units that correspond to glass-forming monomer species.
[0046] The number average molecular weight (Mn) of the block copolymers of the present invention typically range, for example, from about 1000 to about 2,000,000, more typically from about 10,000 to about 300,000, even more typically 50,000 to 150,000, with the BCB- olefin units typically comprising 0.01-60 mol %, more typically 0.5-40 mol %, even more typically 0.5-5 mol % of the polymer. In some embodiments, polymers have a narrow molecular weight distribution such that the ratio of weight average molecular weight to number average molecular weight (Mw/Mn) (i.e., the polydispersity index) of the polymers ranges from about 1.0 to about 2.5, or even from about 1.0 to about 1.2.
[0047] Living polymerization, i.e., a polymerization that proceeds in the practical absence of chain transfer and termination, is a desirable objective in polymer synthesis. Living cationic polymerization implies that a polymer can be grown from one or from a plurality of active sites in a controlled manner (controlled molecular weight, molecular weight distribution, end functionalities, etc.). During this growth process, different molecules can be incorporated into the backbone of the polymer, yielding polymers with well-defined structures. For example, poly(styrene-δ/oc£-isobutylene-δ/oc£-styrene) ("SIBS") is a polymer where isobutylene is grown to a certain block size from two ends of a difunctional seed molecule and then styrene is infused into the reaction to cap the growing chain with glass-forming monomer segments. The result is a thermoplastic triblock polymer of polystyrene -polyisobutylene -polystyrene. One of the advantages of this type of polymer system is that depending upon the molar ratio of styrene to isobutylene, polymers can be made with durometers from Shore 2OA to Shore 9OD with a wide range of elongations. Another advantage of this triblock over a simple random polymerization of isobutylene and styrene is that the polymer blocks thus formed can segment into different domains which dramatically improve physical properties such as tensile strength, tear strength and compression set.
[0048] For certain other embodiments of the invention, when the copolymers of the present invention are random copolymer, conventional polymerization is employed in polymer synthesis. Random copolymers are formed by polymerizing monomer mixtures of (a) branched alkene monomer species (e.g., isobutylene) and (b) BCB-olefin monomer species (e.g., 4-vinylbenzocyclobutene or 2-(4-benzocyclobutenyl)-propene).
[0049] In some embodiments of the present invention, block copolymers are formed by the sequential monomer addition technique using (a) branched alkene monomer species (e.g., isobutylene) and (b) BCB-olefin monomer species (e.g., 4-vinylbenzocyclobutene or 2-(4- benzocyclobutenyl)-propene). As above, in some embodiments, a mixture of BCB-olefin and glass-forming monomer species may be used instead of BCB-olefin monomer species alone.
[0050] In one embodiment, the copolymers of the present invention are block copolymers containing (a) one or more olefin monomer blocks, which contain a plurality of units corresponding to one or more branched alkene monomer species, such as isobutylene, copolymerized with (b) one or more BCB-olefin monomer species, to produce a polymer comprised of polyisobutylene (or other polyalkene) dispersed with BCB crosslinkable units. In the presence of heat, for instance temperatures above 18O0C, these polyisobutylene polymers containing BCB crosslinking units crosslink into 3-dimentional thermoset materials.
[0051] In another embodiment, the copolymers described above containing polyisobutylene co-polymerized with BCB can be mixed in the melt (below 18O0C) with other copolymers. The other copolymer may be, for instance, block copolymers containing (a) one or more glass-forming monomer blocks, which contain a plurality of units corresponding to one or more glass-forming monomer species, such as alpha-methyl styrene, copolymerized with (b) one or more BCB-olefm monomer species to produce a copolymer comprised of poly(alpha-methyl styrene) (or other glass-forming monomer) dispersed with BCB crosslinkable units. In the presence of heat, for instance temperatures above 18O0C, these polyisobutylene polymers containing BCB crosslinkable units can crosslink to the poly(alpha- methyl styrene) polymers containing BCB crosslinkable units to form 3-dimentional thermoset materials that, depending upon the ratios of the above copolymers, can provide rubbery to stiff materials with exceptional physical and chemical properties.
[0052] In many embodiments, the polymer is formed at low temperature from a reaction mixture that comprises: (a) a solvent system appropriate for cationic polymerization, (b) one or more branched alkene monomer species, (c) an initiator, and (d) a Lewis acid coinitiator. In addition, a proton-scavenger is also typically provided to ensure the practical absence of protic impurities, such as water, which can lead to polymeric contaminants in the final product. An inert nitrogen or argon atmosphere is generally required for the polymerization.
[0053] Polymerization can be conducted, for example, within a temperature range of from about 0 0C to about -100 0C, more typically from about -50 0C to -90 0C. Polymerization times are typically those times that are sufficient to reach the desired conversion.
[0054] Among the solvent systems appropriate for cationic polymerization, many of which are well known in the art, are included: (a) C1-C4 halogenated hydrocarbons, such as methyl chloride and methylene dichloride, (b) Cs-Cg aliphatic hydrocarbons, such as pentane, hexane, and heptane, (c) C5-C10 cyclic hydrocarbons, such as cyclohexane and methyl cyclohexane, and (d) mixtures thereof. For example, in some beneficial embodiments, the solvent system contains a mixture of a polar solvent, such as methyl chloride, methylene chloride and the like, and a nonpolar solvent, such as hexane, cyclohexane or methylcyclohexane and the like.
[0055] Initiators for living carbocationic polymerization are commonly organic ethers, organic esters, organic alcohols, or organic halides, including tert-ester, tert-ether, tert- hydroxyl and tert-halogen containing compounds. Specific examples include alkyl cumyl ethers, cumyl halides, alkyl cumyl esters, cumyl hydroxyl compounds and hindered versions of the same, for instance, dicumyl chloride, 5-tert-butyl,l,3-dicumyl chloride, and 5-tert-butyl- 1 ,3 -bis( 1 -methoxy- 1 -methylethyl)benzene . 5 -tert-butyl- 1 ,3 -bis( 1 -methoxy- 1 - methylethyl)benzene is the preferred initiator for cationic polymerization and may be prepared through the methods disclosed in Wang B. et al., "Living carbocationic polymerization XII. Telechelic polyisobutylenes by a sterically hindered bifunctional initiator" Polym. Bull. (1987)17:205-11; or Mishra M.K., et al., "Living carbocationic polymerization VIII. Telechelic polyisobutylenes by the MeO(CH2)2C-p-C5H4-C(CH3)2 OMe/BCl3 initiating system" Polym. Bull. (1987) 17:7-13, both of which are herein incorporated by reference in their entirety. The initiators used for crosslinkable polyolefms described in this invention include mono or multifunctional initiators.
[0056] Carbocationically terminated star polymers can be formed by selecting initiators having three or more initiation sites, for example, tricumyl chloride (i.e., l,3,5-tris(l-chloroy- l-methylethyl)benzene), which contains three initiation sites.
[0057] Examples of Lewis acid coinitiators include metal halides such as boron trichloride, titanium tetrachloride and alkyl aluminum halides. The Lewis acid coinitiator is typically used in concentrations equal to or greater, e.g., 2 to 50 times greater, than the concentration of the initiator.
[0058] Examples of proton-scavengers (also referred to as proton traps) include substituted or unsubstituted 2,6-di-tert-butylpyridines, such as 2,6-di-tert-butylpyridine and 4-methyl-2,6- di-tert-butylpyridine, as well as l,8-bis(dimethylamino)-naphthalene and diisopropylethyl amine. The concentration of the proton trap is preferably only slightly higher than the concentration of protic impurities such as water in the polymerization system.
[0059] Further information regarding the preparation of block copolymers from monomer species that have significantly different reactivities can be found, for example, in United States Patent Application No. 20050187414, herein incorporated by reference in its entirety.
[0060] A beneficial aspect of this invention is that the polymers make excellent thermoplastics. The resultant thermoplastic polymer can be cleaned by multiple dissolution and precipitation procedures, which can be especially useful in medical applications, as it is still soluble in solvents. In addition, the polymer can then be molded or extruded or cast into its desired shape and then heat cured to react the olefin having the pendant BCB group with itself to crosslink the polymer into a thermoset shape. The resultant product provides better heat stability, better creep resistance, less water uptake, and less swelling or solubility in organic solvents. Another advantage of a thermoset polymer is that the polymer can be heat or solvent compounded with plasticizers including polyisobutylene, mineral oil, paraffin oil and the like to soften the polymer.
[0061] Once crosslinked, the polymer can be used for heart valves, vertebral disks, dynamic stabilizers, sealable vascular grafts, stent grafts, intraocular lens (e.g., accommodating intraocular lenses), glaucoma drainage implants, pacemaker headers, pacemaker lead insulators and other implantable medical devices as well as other medical devices where exceptional compression set or creep resistance are important. Additionally, the polymers have use for various uses outside the biomedical field, such use as O-rings or as components of windshield wipers.
[0062] The invention is further described with reference to the following non-limiting examples.
Example 1 : Synthesis of polv(st-co-4VBCB)-polvIB-polv(st-co-4VBCB) triblock copolymer
[0063] 337 mL of methylcyclohexane (MeCHx) were added to a glass reaction vessel equipped with mechanical stirrer, stainless steel serpentine tubing for liquid nitrogen cooling, stainless steel tubing for feeding methyl chloride (MeCl) and isobutylene (IB) into the vessel, a thermocouple with temperature controller, a nitrogen bubbler and an addition dropping funnel. The liquid was cooled down to -80 0C by liquid nitrogen cooling. Sequentially MeCl (189g) and IB (2Og) were added through the feeding line immersed in the liquid, so that the gases are condensed into the liquid. While gases were being condensed, an initiator solution (HDCE/DTBP/MeCHx 0.28g/0.45mL/15mL) was added through a port on the reactor lid. TiCl4 (3.5 mL, use a 10 cc glass syringe) was then added through an opening in the reactor lid, which started the IB polymerization (the timer is started). Forty minutes later, ~4 mL of reaction mixture was withdrawn from the reactor and quenched in excess methanol. A mixture of styrene/4VBCB/MeCHx (7mL/2mL/20mL) was added slowly into the reactor through a syringe in 2 minutes. After 6 minutes, the reaction was quenched with excess methanol.
[0064] The reaction mixture was stored under the fume hood overnight. The top layer was separated and washed repeatedly with distilled water until neutral. The solution was precipitated into isopropyl alcohol, followed by dissolution in toluene and precipitation in isopropyl alcohol again. The precipitate was dried in a vacuum oven at ~60 0C until constant weight (yield: 22g).
[0065] The polymer was characterized by GPC and NMR. As shown in Figure 1 , both the starting PIB (low elution volume) and the triblock copolymer (high elution volume) show a narrow monodispersed peak in GPC RI traces, and the traces shift smoothly as molecular weight increases. As shown in Figure 2, there is a singlet at ~3.1 ppm in proton NMR spectrum, which is attributed to the strained ring of BCB. The broad peaks at -6.4-7.3 ppm are attributed to aromatic protons on styrene and 4-VBCB monomer units. From the relative integration intensities, the copolymer was determined to have ~3 mol% 4-VBCB and ~7 mol% styrene.
Example 2: Synthesis of poly(IB-co-4VBCB) random copolymer
[0066] 337 mL of methylcyclohexane (MeCHx) were added to a glass reaction vessel equipped with mechanical stirrer, stainless steel tubing for liquid nitrogen cooling, stainless steel tubing for feeding methyl chloride (MeCl) and isobutylene (IB) into the vessel, a thermocouple with temperature controller, a nitrogen bubbler and an addition dropping funnel. The liquid was cooled down to -80 0C by liquid nitrogen cooling. Sequentially MeCl (189g) and IB (5g) were added through the feeding line immersed in the liquid, so that the gases are condensed into the liquid. While gases are being condensed, an initiator solution (HDCE/DTBP/MeCHx 0.28g/0.45mL/15mL) was added through a port on the reactor lid. TiCl4 (3.5 mL, using a 10 cc glass syringe) was then added through an opening in the reactor lid, which starts the IB polymerization (the timer was started). Five minutes later, 36g of IB and 1.5g 4VBCB (dissolved in 10 niL of MeCHx) were added slowly, taking 7 min and 9.5 min, respectively. After all 4-VBCB was added, the reaction is kept going for 60 min. Samples were taken at 5, 30 and 60 min. The reaction was quenched with excess methanol in the end.
[0067] The reaction mixture was stored under the fume hood overnight. The top layer was separated and washed repeatedly with distilled water until neutral. The solution was precipitated into isopropyl alcohol, followed by dissolution in hexane and precipitation in isopropyl alcohol again. The precipitate was dried in a vacuum oven at ~60 0C until constant weight (yield: 35g).
[0068] The polymer was characterized by GPC and proton NMR. GPC RI traces of the samples show (see Figure 3) that the molecular weight increases with reaction time. Little change was observed in molecular weight (-10%) from 30min to 60min, as the polymerization approached completion. Each sample had a UV signal with similar elution volume as its RI signal (Figure 3, 4). The sample taken at 5 min exhibited a much stronger UV signal than the other two, indicating that it has a higher 4-VBCB content at lower conversion. The incorporation of 4-VBCB into the copolymer was further confirmed by proton NMR spectroscopy. A singlet at ~3.1 ppm was seen in proton NMR spectrum (Figure 5), which is attributed to the strained ring of BCB.
[0069] When heated up to 24O0C for 10 min, the copolymer became insoluble in THF and thus thermally crosslinked.
Example 3: Thermal crosslinking of polv(st-co-4VBCB)-polvIB-polv(st-co-4VBCB) triblock copolymer
[0070] A sample (0.2g) of the poly(st-co-4VBCB)-polyIB-poly(st-co-4VBCB) triblock copolymer as formed above was placed between two Teflon films, and the films placed between two flat metal plates. The resulting structure was placed in a hot press (250 0C) for 10 minutes with virtually no pressure applied. The Teflon films were removed from the plates and cooled to room temperature. A small piece of the heat treated polymer was placed in a vial containing THF. The film remained insoluble overnight and longer, indicating that it crosslinked. [0071] Polymer samples were thermally treated at different temperatures for 10 minutes. At temperatures above 220 0C, the resultant polymer is insoluble in THF. At a temperature of 200 0C, the resultant polymer is soluble in THF. For thermal crosslinking below 220 0C, extended time period (>10 min) may be necessary.
Example 4: Preparation of a SIBS triblock polymer
[0072] SIBS was prepared in two steps in one pot. In the first step, isobutylene was polymerized by a 5-tert-butyl,l,3-dicumyl chloride/TiCU initiating system in a methyl chloride/hexanes solvent system in the presence of a proton trap under a blanket of dry nitrogen at -8O0C. When the central PIB block reached the desired molecular weight, in this case 50 KDaltons, a sample was removed from the reactor and styrene was added to the reactor and the polymerization continued until the outer polystyrene blocks also reach a predetermined length, in this case 75 KDaltons. The process was terminated by the addition of methanol. The sample that was taken was dried in an oven. After drying in the oven, the sample was observed to have a consistency similar to that of a rubber band.
Example 5: Comparative example using 1-hexene
[0073] This experiment was run to compare the effect of polyisobutylene, as described in Example 4, with 1-hexene. 1-hexene was dissolved in a methyl chloride/hexanes solvent system and the mixture was added to the reaction pot in the presence of a 5-tert-butyl,l,3- dicumyl chloride/TiCU initiating system, also in a methyl chloride/hexanes solvent system, in the presence of a proton trap under a blanket of dry nitrogen at -8O0C. However, in this case, at the end of the addition, a sample was taken which when dry, resembled a lumpy oil. The reaction never went to completion because to chain termination effects. The styrene was never added to the reactor as the experiment was aborted.
[0074] Based on these results, it was concluded that 1-hexene could not achieve an elastomer by cationic polymerization. Instead, the reaction produced low molecular weight oils.
[0075] In accordance with another aspect of the invention, the polymeric material as described herein realizes an intraocular lens (IOL) for the replacement of the natural crystalline lens of the eye. The natural crystalline lens is a gel-like material that sits within the lens capsule of the eye and when the lens capsule is stretched by the zonules, the gel changes its thickness and therefore its focal point thereby allowing focusing at different distances. When the natural lens is removed from the lens capsule, lens epithelial cells (LECs) begin to multiply and spread on the posterior wall of the lens capsule and effectively render the posterior wall opaque (referred to as "posterior capsule opacification" or PCO), which results in impaired vision. The LECs also spread on the anterior wall. However, due to the opening in the anterior wall of the lens capsule (the capsulorrhexus) employed in traditional IOL implantations, there is no wall for them to spread onto. The occurrence of PCO is relatively high in traditional IOL implantations where the LECs spread between the IOL and the lens capsule.
[0076] In the preferred embodiment, the polymeric material as described herein is used to form a one-piece IOL that includes an optic portion with an outer peripheral edge as well as one or more haptic elements (or haptics) that project radially outward from the peripheral edge of optic portion as shown in FIGS. 6 - 8C.
[0077] In the embodiment of FIG. 6, the IOL 100 includes an optic portion 102 with an outer peripheral edge 103. Three haptic elements 104A, 104B, 104C (collectively, 104) project radially outward from the peripheral edge 103 of optic portion 102. The haptic elements 104 are preferably integrally formed with and permanently connected to the outer peripheral edge 103 of optic portion 102. Different haptic designs, such as those that utilize two haptics or four haptics can also be used.
[0078] In the embodiment of FIGS. 7 - 8 A, the IOL 100' employs a ring haptic 104' as is well known in the art. FIG. 7 illustrates a top view of the IOL 100' with an optic portion 102" and a ring haptic 104'. Cross-sections for different embodiments are shown in FIGS. 8A-8C. The front and back surfaces of optic portion 102' can be of any diopter (curvature) necessary to provide the desired correction for the patient. For example, the front surface of the optic portion 104' may be convex as shown in FIGS. 8A-8C or possibly concave (not shown). The back surface of the optic portion 104' is preferably flat as shown in FIGS. 8A-8C, but it may be concave or convex to add or subtract magnification. As shown in FIGS. 8A-C, the angle θ of the annulus of the ring haptic 104' relative to the plane of the optic portion 104' (which is disposed substantially perpendicular to the optical axis of the eye) is between 0 and 45 degrees, and more preferably between 10 and 20 degrees, and most preferably 15 degrees.
[0079] The terminal end(s) of the haptic(s) of the IOL as described herein are adapted to rest in and engage the lens capsule where such terminal end(s) is(are) held in place through compressive forces exerted by the inner surfaces of the lens capsule. The haptic(s) preferably do not lie in the plane of the optic portion but are angled relative to the optic portion (for example, at 15 degrees) such that posterior side of the optics portion presses against and contacts the posterior wall of the lens capsule. This configuration (which is typically referred to as a "vaulted configuration" or "vaulted haptics") is important because the pressure of the optics portion against the posterior wall of the lens capsule prevents epithelial cells from migrating between the optics portion and the posterior wall and thereby mitigates the occurrence of PCO. Moreover, due to the crosslinked nature of the polymeric material as described herein, the vaulted haptics realized from such polymeric material maintain pressure of the optics portion against the posterior wall of the lens capsule over time and thus mitigates the occurrence of PCO over time.
[0080] In addition, when accommodation is desired, the haptics of the IOL act as a hinge which allows the optics portion to move forward or backwards along the optical axis of the eye. The crosslinked nature of the polymeric material as described herein allows for such hinged movement while providing memory that returns the haptics to their original shape during such accommodation. Moreover, the polymeric material as described herein better resists fatigue under the flex stresses imposed during accommodation as compared to the acrylic lenses currently on the market. More specifically, acrylic lenses are not used for accommodating IOLs for this reason. Typically, silicone is used for accommodating IOLs, but silicone IOLs are thick In addition, silicone swells when silicone oil is used following victrectomy; that is when the vitreous humor is removed and replaced with silicone oil, the silicone IOL will swell. Silicone oil has no effect on an IOL realized from the polymeric material as described herein.
[0081] The polymeric material as described herein provides an index of refraction in the range between 1.525 and 1.535 as compared to an index of refraction between 1.25 and 1.42 for silicone rubber. This higher index of refraction provides greater magnification as compared to silicone rubber, which enables the IOL realized from the polymeric material described herein to be thinner than silicone rubber IOLs. A thin IOL is advantageous as it can be introduced into lens capsule through a smaller size cannula and thus reduces the size of the surgical incision into the lens capsule. The reduced size incision lessens the chance of an astigmatism that can possibly result therefrom when the incision is sutured closed. Moreover, it is contemplated that the thin IOL can be deployed into the lens capsule through an incision less than 2.5mm. In this case, a suture is not necessary to close the incision and astigmatisms are not a concern.
[0082] In the preferred embodiment, the polymeric material of the IOL includes PIB crosslinked by at least one BCB-olefm monomer as described herein due to the homogeneity of such material. It is also contemplated that the polymeric material of the IOL can be made gel like to form a phako-ersatz lens. In this embodiment, the polymeric material as described herein can be made into a gel for realizing the IOL by blending in, either with heat or in solvent, plasticizers such as low molecular weight PIB, mineral oil, paraffin oil, organic solvents (toluene, hexane, heptane, octane, nonane, decane, dodecane, etc.) or any other aliphatic plasticizer. For example, at 90% plasticizer, the polymeric material as described herein becomes jell-o-like.
[0083] When PIB is used as part of the polymeric material of the IOL, the PIB is typically synthesized in organic solvent using a Lewis acid as an initiator. One such Lewis acid that is preferred for this application is titanium tetrachloride. In order to quench the reaction, chemicals such as alcohols (methanol, for example) are added in excess to the reaction stoicheometry which immediately quenches the reaction by neutralizing titanium tetrachloride. At completion of the reaction, titanium tetrachloride is converted into various salts of titanium, including titanium dioxide, titanium methoxide, and the like. In addition, depending upon the reaction vessel used, various salts of titanium can form with materials inherent to the reaction vessel, especially if the vessel is comprised of stainless steel - these salts render the material black with time. Nevertheless, a consequence of adding these reactant materials is that in order to render the material clean and highly transparent, these excess materials and their byproducts must be removed from the polymer upon completion of the reaction. These remnant salts and other unwanted chemicals are preferably washed from the PIB material by washing the polymer in a separatory funnel with salt water, with pure water and with repeated precipitations in excess polar solvent (such as isopopanol, acetone, methanol, ethanol and the like). Other well-known washing procedures can also be used. Note that if the material is not washed of salts, these hygroscopic salts begin to draw in water when the material is equilibrated in water. Voids where the salts have been trapped are readily viewed under scanning electron microscopy and these voids become filled with water as the salt is dissolved out. As water has a refractive index of approximately 1.33 and material has a refractive index of 1.53, the difference in refractive index is sufficient to render the polymer cloudy and at times totally opaque. If the material is washed appropriately, these salts are removed and voids no longer exist.
[0084] When used as an IOL, the polymer can be compounded with radiopaque fillers and the like to enable visualization under X-ray or angiography. Other fillers and additives known in the art of preparing an IOL can also be added using known techniques and procedures.
[0085] There have been described and illustrated herein several embodiments of polymers and crosslinked polyolefms for biomedical applications as well as methods of making same. While particular embodiments of the invention have been described, it is not intended that the invention be limited thereto, as it is intended that the invention be as broad in scope as the art will allow and that the specification be read likewise. It will therefore be appreciated by those skilled in the art that yet other modifications could be made to the provided invention without deviating from its spirit and scope as claimed.

Claims

WHAT IS CLAIMED IS:
1. A polymer, comprising:
(a) a plurality of constitutional units that include at least one cationically polymerizable branched alkene monomer;
(b) a plurality of constitutional units that include at least one cationically polymerizable olefin monomer having a pendant benzocyclobutene (BCB) group; and optionally
(c) a plurality of constitutional units that include at least one glass-forming monomer.
2. A polymer according to claim 1, wherein said branched alkene monomer is an isoolefm.
3. A polymer according to claim 2, wherein said isoolefm is isobutylene.
4. A polymer according to claim 1, wherein said olefin monomer having a pendant BCB group has the formula
Figure imgf000023_0001
wherein R is hydrogen or an alkyl group and n is 0.
5. A polymer according to claim 4, wherein said olefin monomer having a pendant BCB group is 4-vinylbenzocyclobutene or 2-(4-benzocyclobutenyl)-propene.
6. A polymer according to claim 1, wherein said olefin monomer having a pendant BCB group has the formula
Figure imgf000023_0002
wherein R is alkyl group and n is an integer ranging from 0-3.
7. A polymer according to claim 6, wherein said olefin monomer having a pendant BCB group is 2-methyl-3-(4-benzocyclobutenyl)-propene.
8. A polymer according to claim 1, wherein said glass-forming monomer is present and selected from the group consisting of styrene, indene, α-methylstyrene, p-tert-butylstyrene, p- chlorostyrene, p-methoxystyrene, p-tert-butoxystyrene, p-hydroxystyrene, norbornene, and combinations thereof.
9. A polymer according to claim 1, wherein the alkene monomer is isobutylene, the olefin monomer having a pendant BCB group is 4-vinylbenzocyclobutene, and the glass-forming monomer is present and is styrene.
10. A polymer according to claim 1, wherein the polymer is a thermoplastic polymer.
11. A polymer according to claim 1 , wherein the polymer is chemically crosslinked.
12. A polymer according to claim 1, wherein the polymer is a triblock copolymer.
13. A polymer according to claim 1, wherein the polymer is a random copolymer.
14. A method of preparing a polymer comprising cationically polymerizing
(a) at least one branched alkene monomer;
(b) at least one olefin monomer having a pendant benzocyclobutene (BCB) group; and optionally
(c) at least one glass-forming monomer.
15. A method according to claim 14, wherein said alkene monomer is isobutylene.
16. A method according to claim 14, wherein said olefin monomer having a pendant BCB group has the formula
Figure imgf000025_0001
wherein R is hydrogen or an alkyl group and n is 0.
17. A method according to claim 14, wherein said olefin monomer having a pendant BCB group has the formula
Figure imgf000025_0002
wherein R is alkyl group and n is an integer ranging from 0-3.
18. A method according to claim 14, wherein the cationic polymerization step involves living cationic polymerization.
19. A method according to claim 14, further comprising the step of exposing the polymer to temperatures of at least 18O0C to initiate crosslinking.
20. A method according to claim 14, wherein the polymerization reaction takes place in the presence of an initiator that comprises 5-tert-butyl-l,3-bis(l-methoxy-l-methylethyl)benzene.
21. An intraocular lens, comprising a polymer that comprises:
(a) a plurality of constitutional units that include at least one cationically polymerizable branched alkene monomer;
(b) a plurality of constitutional units that include at least one cationically polymerizable olefin monomer having a pendant benzocyclobutene (BCB) group; and optionally
(c) a plurality of constitutional units that include at least one glass-forming monomer.
22. The intraocular lens according to claim 21, wherein the polymer further comprises plasticizers, radiopaque fillers, or a combination thereof.
23. The intraocular lens according to claim 21, wherein the polymer has an index of refraction ranging from about 1.525 to about 1.535.
24. The intraocular lens according to claim 22, wherein the polymer is blended with a plasticizer in sufficient amounts so that polymer becomes a gel.
PCT/US2008/072482 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of making same Ceased WO2009061534A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA2705143A CA2705143C (en) 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of making same
KR1020107012514A KR101523239B1 (en) 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of making same
JP2010533131A JP5605706B2 (en) 2007-11-08 2008-08-07 Crosslinked polyolefin for biomedical applications and process for producing the same
EP08797379A EP2225291B1 (en) 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of making same
BRPI0818904-8A BRPI0818904A2 (en) 2007-11-08 2008-08-07 Cross-linked polyolefins for biomedical applications and method of fabricating them
CN200880124361.XA CN101918461B (en) 2007-11-08 2008-08-07 Cross-linked polyolefin for biomedical use and method for its manufacture
MX2010005098A MX2010005098A (en) 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of making same.
ES08797379T ES2408754T3 (en) 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of manufacturing them

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US98638407P 2007-11-08 2007-11-08
US60/986,384 2007-11-08
US12/145,704 2008-06-25
US12/145,704 US8765895B2 (en) 2007-11-08 2008-06-25 Crosslinked polyolefins for biomedical applications and method of making same

Publications (1)

Publication Number Publication Date
WO2009061534A1 true WO2009061534A1 (en) 2009-05-14

Family

ID=40624382

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/072482 Ceased WO2009061534A1 (en) 2007-11-08 2008-08-07 Crosslinked polyolefins for biomedical applications and method of making same

Country Status (10)

Country Link
US (4) US8765895B2 (en)
EP (1) EP2225291B1 (en)
JP (1) JP5605706B2 (en)
KR (1) KR101523239B1 (en)
CN (2) CN101918461B (en)
BR (1) BRPI0818904A2 (en)
CA (1) CA2705143C (en)
ES (1) ES2408754T3 (en)
MX (1) MX2010005098A (en)
WO (1) WO2009061534A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011071673A1 (en) * 2009-12-11 2011-06-16 Bausch & Lomb Incorporated An intraocular lens incorporating a uv - absorbing benzotriazole
US9220888B2 (en) 2012-04-02 2015-12-29 Medtronic, Inc. Medical leads

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
EP2647353B1 (en) 2007-07-23 2014-12-31 PowerVision, Inc. Lens delivery system
AU2008279167B2 (en) 2007-07-23 2014-10-09 Alcon Inc. Post-implant lens power modification
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
JP5346022B2 (en) 2007-07-23 2013-11-20 パワーヴィジョン・インコーポレーテッド Accommodating intraocular lens and method of use
US8765895B2 (en) * 2007-11-08 2014-07-01 Innolene Llc Crosslinked polyolefins for biomedical applications and method of making same
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
US8585940B2 (en) * 2009-05-08 2013-11-19 Innolene Llc Ocular lens
EP2473138A4 (en) 2009-08-31 2017-08-16 PowerVision, Inc. Lens capsule size estimation
EP3263574B1 (en) 2010-02-23 2019-04-03 PowerVision, Inc. Accomodating intraocular lens
US9220590B2 (en) 2010-06-10 2015-12-29 Z Lens, Llc Accommodative intraocular lens and method of improving accommodation
WO2012006616A2 (en) 2010-07-09 2012-01-12 Powervision, Inc. Intraocular lens delivery devices and methods of use
EP3928744A1 (en) 2011-03-24 2021-12-29 Alcon Inc. Intraocular lens loading systems and methods of use
JP5791418B2 (en) * 2011-07-29 2015-10-07 キヤノン株式会社 Novel compound, polymer, cross-linked product thereof, and optical element having the same
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
US9101444B2 (en) 2012-01-12 2015-08-11 Innfocus, Inc. Method, surgical kit and device for treating glaucoma
US9364318B2 (en) 2012-05-10 2016-06-14 Z Lens, Llc Accommodative-disaccommodative intraocular lens
US8940810B2 (en) * 2012-06-07 2015-01-27 Canon Kabushiki Kaisha Optical component, electronic board, method for producing the optical component, and method for producing the electronic board
EP2967842B1 (en) 2013-03-15 2020-11-04 Alcon Inc. Method of reconfiguring an intraocular lens for delivery to a delivery device
JP6839100B2 (en) 2015-06-10 2021-03-03 アルコン インコーポレイティド Intraocular lens materials and components
CA3001477A1 (en) 2015-11-06 2017-05-11 Alcon Inc. Accommodating intraocular lenses and methods of manufacturing
CN107440818A (en) * 2016-06-01 2017-12-08 西安浦勒生物科技有限公司 A kind of new back room artificial lens based on innovation biocompatibility hydrophobic material
JP7074960B2 (en) 2016-08-24 2022-05-25 カール ツァイス メディテック アーゲー Dual Mode Adjustable-Non-Adjustable Intraocular Lens
CN107501459A (en) * 2017-08-25 2017-12-22 江苏明魁高分子材料技术有限公司 Crosslinkable polymer and its synthetic method and application with high-carbon content and controllable optical index
CN111205383B (en) * 2020-02-28 2021-04-02 西北工业大学 Random copolymer, preparation method and application thereof, modified PBO fiber and preparation method thereof
CN113367885B (en) * 2020-03-10 2022-07-29 成都米戈思医疗技术有限公司 Glaucoma drainage tube, material thereof and implantation device
CN113855862A (en) * 2020-06-30 2021-12-31 四川大学华西医院 An anti-scar film and its material for glaucoma filtration surgery
WO2022205473A1 (en) * 2021-04-02 2022-10-06 杭州新聚医疗科技有限公司 Thermally cross-linkable polymer for forming elastic material used as foldable intraocular lens, preparation method therefor and use thereof
CN116425930A (en) * 2021-09-30 2023-07-14 北京石油化工学院 Polyisomonoolefin Copolymer, Initiator System and Application
CN115569245A (en) * 2022-09-23 2023-01-06 西安眼得乐医疗科技有限公司 Eye implant and preparation method and application thereof
EP4734876A1 (en) 2023-06-30 2026-05-06 Alcon Inc. System and methods for compensating for intraocular lens tilt
CN120158028A (en) * 2023-12-07 2025-06-17 台光电子材料(昆山)股份有限公司 Resin composition and its products
CN119552326A (en) * 2024-04-17 2025-03-04 成都米戈思医疗技术有限公司 Polyisobutylene-based copolymer and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780954B2 (en) * 1991-10-15 2004-08-24 Dow Global Technologies, Inc. Elastic substantially linear ethylene polymers
WO2004072133A1 (en) 2003-02-05 2004-08-26 Dow Global Technologies Inc. Sacrificial styrene benzocyclobutene copolymers for making air gap semiconductor devices
WO2004073018A2 (en) 2003-02-05 2004-08-26 Dow Global Technologies Inc. Sacrificial benzocyclobutene/norbornene polymers for making air gaps within semiconductor devices
US20060173145A1 (en) * 2005-02-01 2006-08-03 Pawlow James H Multi-functionalized high-trans elastomeric polymers

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4667004A (en) * 1985-12-23 1987-05-19 Shell Oil Company Olefinic benzocyclobutene polymers
US4622375A (en) * 1986-03-28 1986-11-11 Shell Oil Company Amorphous ethylene/propylene polymers
EP0227124B2 (en) * 1985-12-23 1996-01-31 Shell Internationale Researchmaatschappij B.V. Olefinic benzocyclobutene polymers and processes for the preparation thereof
US4687815A (en) * 1985-12-23 1987-08-18 Shell Oil Company Hydrogenated block copolymers
US4667005A (en) * 1985-12-23 1987-05-19 Shell Oil Company Crystalline alphamonoolefin copolymers
US4698394A (en) * 1985-12-23 1987-10-06 Shell Oil Company Reactive styrene polymers
US4946899A (en) * 1988-12-16 1990-08-07 The University Of Akron Thermoplastic elastomers of isobutylene and process of preparation
US5077367A (en) * 1989-09-29 1991-12-31 The Dow Chemical Company Crystalline syndiotactic copolymers from arylcyclobutene functional monomers and vinyl aromatic monomers
ATE161021T1 (en) * 1991-07-15 1997-12-15 Exxon Chemical Patents Inc LIVING CARBOCATIONIC POLYMERIZATION PROCESS
US5422410A (en) * 1992-10-27 1995-06-06 The Dow Chemical Company Method for increasing the molecular weight of thermoplastic polymers of monoalkenyl arenes
US5516610A (en) * 1994-08-08 1996-05-14 Hewlett-Packard Company Reusable inverse composite dual-layer organic photoconductor using specific polymers
WO1996016094A1 (en) * 1994-11-23 1996-05-30 The Dow Chemical Company Preparation of syndiotactic polyolefins from prochiral olefins
US5741331A (en) 1996-07-29 1998-04-21 Corvita Corporation Biostable elastomeric polymers having quaternary carbons
US6268451B1 (en) 2000-10-03 2001-07-31 University Of Massachusetts Lowell Silyl-functional pseudo-telechelic polyisobutylene terpolymers
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
DE60120497T2 (en) * 2000-12-20 2007-06-06 Exxonmobil Chemical Patents Inc., Baytown METHOD FOR POLYMERIZING CATIONIC POLYMERIZABLE MONOMERS
US6512056B1 (en) * 2001-03-09 2003-01-28 The University Of Akron Star polymers having statistical poly(isobutylene-co-styrene) copolymer arms
WO2004035680A1 (en) 2002-10-17 2004-04-29 Dow Global Technologies Inc. Highly filled polymer compositions
US20050187414A1 (en) 2003-07-31 2005-08-25 Rudolf Faust Copolymers comprising branched olefin and vinyl ether units
CN100374448C (en) * 2005-12-30 2008-03-12 四川大学 Preparation method of diene-siloxane bridged bis-benzocyclobutene monomer and prepolymer
US8765895B2 (en) 2007-11-08 2014-07-01 Innolene Llc Crosslinked polyolefins for biomedical applications and method of making same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780954B2 (en) * 1991-10-15 2004-08-24 Dow Global Technologies, Inc. Elastic substantially linear ethylene polymers
WO2004072133A1 (en) 2003-02-05 2004-08-26 Dow Global Technologies Inc. Sacrificial styrene benzocyclobutene copolymers for making air gap semiconductor devices
WO2004073018A2 (en) 2003-02-05 2004-08-26 Dow Global Technologies Inc. Sacrificial benzocyclobutene/norbornene polymers for making air gaps within semiconductor devices
US20060173145A1 (en) * 2005-02-01 2006-08-03 Pawlow James H Multi-functionalized high-trans elastomeric polymers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DE ET AL.: "Relative Reactivity of C4 Olefins toward the Polyisobutylene Cation", MACROMOLECULES, vol. 39, 2006, pages 6861 - 70
See also references of EP2225291A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011071673A1 (en) * 2009-12-11 2011-06-16 Bausch & Lomb Incorporated An intraocular lens incorporating a uv - absorbing benzotriazole
US9220888B2 (en) 2012-04-02 2015-12-29 Medtronic, Inc. Medical leads

Also Published As

Publication number Publication date
CN105330775A (en) 2016-02-17
JP5605706B2 (en) 2014-10-15
KR20100096142A (en) 2010-09-01
EP2225291A4 (en) 2011-06-22
EP2225291A1 (en) 2010-09-08
CN101918461B (en) 2015-09-16
US20140309394A1 (en) 2014-10-16
ES2408754T3 (en) 2013-06-21
MX2010005098A (en) 2010-11-12
BRPI0818904A2 (en) 2015-05-12
US20090124773A1 (en) 2009-05-14
EP2225291B1 (en) 2013-01-02
US10766987B2 (en) 2020-09-08
JP2011503290A (en) 2011-01-27
CA2705143C (en) 2016-03-01
CN101918461A (en) 2010-12-15
US20160311952A1 (en) 2016-10-27
CN105330775B (en) 2018-09-07
US9382357B2 (en) 2016-07-05
CA2705143A1 (en) 2009-05-14
US8765895B2 (en) 2014-07-01
KR101523239B1 (en) 2015-05-27
US20180127525A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
US10766987B2 (en) Crosslinked polyolefins for biomedical applications and method of making same
US20140058008A1 (en) Ocular Lens
KR101433025B1 (en) Method of purifying block copolymers
US20130103148A1 (en) Intraocular Lens
US20030151825A1 (en) Polyacrylate-based light adjustable optical element
WO2022246198A1 (en) Biostable polymer brushes with defined viscosity and optical properties for use in a novel intraocular lens
WO2024233709A2 (en) Fluorinated copolymer bottlebrushes for optical applications
Pusch Strategies of preparing transparent latices with application to the synthesis of transparent hydrogels for intraocular lenses
CZ20002507A3 (en) Hydrophilic-hydrophobic materials based on copolymer of isobutylene with hydroxyalkyl acrylates and methacrylates and process for producing thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880124361.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08797379

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2705143

Country of ref document: CA

Ref document number: 2010533131

Country of ref document: JP

Ref document number: 2705/CHENP/2010

Country of ref document: IN

Ref document number: MX/A/2010/005098

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20107012514

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008797379

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0818904

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100510